Insider Transactions in Q4 2017 at Pieris Pharmaceuticals, Inc. (PIRS)
Insider Transaction List (Q4 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2017
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
147,635
-2.04%
|
$738,175
$5.7 P/Share
|
|
Dec 18
2017
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
147,635
+0.16%
|
$295,270
$2.32 P/Share
|